Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Ligand Pharmaceuticals Stock Price, Quotes and Forecasts
LGNDNASDAQ
Ligand Pharmaceuticals (LGND) Forecast
NewsEarningsLigand Pharmaceuticals (LGND) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Ligand Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:LGND | Benzinga
Explore Ligand Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LGND.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ligand Pharmaceuticals (LGND) stock?
You can purchase shares of Ligand Pharmaceuticals (NASDAQ:LGND) through any online brokerage.
Who are Ligand Pharmaceuticals (LGND) competitors?
Other companies in Ligand Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
What is the forecast, or price target, for Ligand Pharmaceuticals (LGND) stock?
Ligand Pharmaceuticals has a consensus price target of $137.88.
What is the current price for Ligand Pharmaceuticals (LGND)?
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $104.69 last updated May 16, 2025 at 1:04 PM EDT.
Does Ligand Pharmaceuticals (LGND) pay a dividend?
A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 19, 2007 to stockholders of record on April 3, 2007.
When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?
Ligand Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is Ligand Pharmaceuticals (LGND) going to split?
There is no upcoming split for Ligand Pharmaceuticals.
What sector and industry does Ligand Pharmaceuticals (LGND) operate in?
Ligand Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
